EcoDrugPlus

Cholecystokinin B Receptor

Ensembl ID : ENSPKIG00000010223
Gene Symbol: CCKBR
4 Cross references
262 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSPKIG00000011696
Gene Symbol: CCKBR
3 Cross references
262 Possible Orthologues:

Cholesterol 24-Hydroxylase

Ensembl ID : ENSPKIG00000014827
Gene Symbol: LOC111850949
2 Cross references
257 Possible Orthologues:

Cholesteryl Ester Transfer Protein

Ensembl ID : ENSPKIG00000002300
Gene Symbol: CETP
3 Cross references
137 Possible Orthologues:

Cholinergic Receptor Muscarinic 1

Ensembl ID : ENSPKIG00000019172
Gene Symbol: CHRM1
2 Cross references
100 Possible Orthologues:

Cholinergic Receptor Muscarinic 1

Ensembl ID : ENSPKIG00000004905
Gene Symbol: CHRM1
1 Cross references
100 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSPKIG00000000565
Gene Symbol: CHRM2
3 Cross references
185 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSPKIG00000000386
Gene Symbol: CHRM3
1 Cross references
187 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSPKIG00000001786
Gene Symbol: CHRM3
1 Cross references
186 Possible Orthologues:

Cholinergic Receptor Muscarinic 4

Ensembl ID : ENSPKIG00000003537
Gene Symbol: CHRM4
4 Cross references
182 Possible Orthologues:

Cholinergic Receptor Muscarinic 4

Ensembl ID : ENSPKIG00000012549
Gene Symbol: CHRM4
3 Cross references
182 Possible Orthologues:

Cholinergic Receptor Muscarinic 5

Ensembl ID : ENSPKIG00000002319
Gene Symbol: CHRM5
3 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).